Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Willenbacher W"'
Autor:
Brunner A; Department of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria. andrea.brunner@i-med.ac.at., Thalhammer-Thurner GC; Department of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria., Willenbacher W; Internal Medicine V, Haematology & Oncology, Innsbruck Medical University, Innsbruck, Austria.; Syndena GmbH, Connect to Cure, Innsbruck, Austria., Haun M; Department of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria.; Institute of Pathophysiology, Innsbruck Medical University, Innsbruck, Austria., Zelger BG; Department of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria., Willenbacher E; Internal Medicine V, Haematology & Oncology, Innsbruck Medical University, Innsbruck, Austria.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Feb; Vol. 103 (2), pp. 553-563. Date of Electronic Publication: 2023 Nov 11.
Autor:
Dogliotti I; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy., Jiménez C; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain. jscris@usal.es., Varettoni M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Talaulikar D; Canberra Health Services, College of Medicine, Biology and Environment Australian National University, Canberra ACT, Australia., Bagratuni T; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Ferrante M; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy., Pérez J; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., Drandi D; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy., Puig N; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., Gilestro M; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy., García-Álvarez M; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain., Owen R; The Leeds Teaching Hospitals National Health Service Trust, Leeds, UK., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Tedeschi A; ASST Grande Ospedale Metropolitano Niguarda Hospital, Milan, Italy., Leblond V; Département d'Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France., Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Kersten MJ; Department of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., D'Sa S; Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK., Kaščák M; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Willenbacher W; Department of Haematology and Oncology, Internal Medicine V, Innsbruck University Hospital & Syndena GmbH, Connect to Cure, Innsbruck, Austria., Roccaro AM; Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy., Poulain S; Laboratory of Hematology, Biology and Pathology Center, CHU of Lille, INSERM UMR-S 1277, Team 4, Oncolille, Lille, France., Morel P; Service d'Hematologie Clinique et Therapie Cellulaire, Centre Hospitalier Universitaire d'Amiens-Picardie, Amiens, France., Kyriakou C; Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London, UK., Fend F; Institute of Pathology and Comprehensive Cancer Centre, Eberhard-Karls-University, University Hospital Tübingen, Tübingen, Germany., Vos JMI; Department of Hematology, Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Buske C; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany., Ferrero S; Unit of Hematology, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Hematology Division 1U, 'AOU Città della Salute e della Scienza di Torino', Torino, Italy., García-Sanz R; Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.
Publikováno v:
Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 388-395. Date of Electronic Publication: 2022 Nov 26.
Autor:
Willenbacher E; Internal Medicine V. Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria., Willenbacher W; Internal Medicine V. Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria.; Oncotyrol, Centre for Personalized Cancer Medicine, Innsbruck, Austria., Wolf DG; Internal Medicine V. Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria.; Medical Clinic 3, Oncology, Haematology, Rheumatology and Immunoncology, University Clinic Bonn (UKB), Bonn, Germany., Zelger B; Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria., Peschel I; Institute for Medical and Chemical Laboratory Diagnostics, Medical University Innsbruck, Innsbruck, Austria., Manzl C; Division of General Pathology, Department of Pathology, Innsbruck Medical University, Innsbruck, Austria., Haun M; Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria., Brunner A; Institute of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria.
Publikováno v:
British journal of haematology [Br J Haematol] 2019 Jul; Vol. 186 (1), pp. 189-191. Date of Electronic Publication: 2019 Feb 14.
Autor:
Buske C; Comprehensive Cancer Center Ulm, University Hospital of Ulm, Ulm, Germany. Electronic address: christian.buske@uni-ulm.de., Sadullah S; James Paget University Hospital, Norfolk, UK., Kastritis E; National and Kapodistrian University of Athens, Athens, Greece., Tedeschi A; Department of Haematology, Aziende Socio Sanitarie Territoriali Grande Ospedale Metropolitano Niguarda, Milan, Italy., García-Sanz R; Hospital Universitario de Salamanca and Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Bolkun L; Medical University Hospital of Bialystok, Bialystok, Poland., Leleu X; Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, Hôpital de La Milétrie, Centre Hospitalier Universitaire, Poitiers, France., Willenbacher W; Innsbruck Medical University, Innsbruck, Austria; Oncotyrol-Center for Personalized Cancer Medicine, Innsbruck, Austria., Hájek R; Department of Hemato-oncology, University Hospital of Ostrava and Faculty of Medicine Ostrava, University of Ostrava, Ostrava, Czech Republic., Minnema MC; University Medical Center Utrecht, Utrecht, Netherlands., Cheng M; Pharmacyclics LLC, Sunnyvale, CA, USA., Bilotti E; Pharmacyclics LLC, Sunnyvale, CA, USA., Graef T; Pharmacyclics LLC, Sunnyvale, CA, USA., Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2018 Jul; Vol. 5 (7), pp. e299-e309.
Publikováno v:
British journal of haematology [Br J Haematol] 2013 Jun; Vol. 161 (6), pp. 902-4. Date of Electronic Publication: 2013 Apr 05.